CGRP receptor antagonists
US6953790B2 · kind B2 · utility
17Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2004 |
| Grant date | Oct 11, 2005 |
| Priority date | — |
| Expiry date | May 4, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of Formula I: and Formula II: (where variables R1, R2, R3, R4, A, B, G, J, Q, T, U, V, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.